Share
Explore BrainMass

Global Partnership

Discuss some of the advantages of how global partnerships can assist in solving or reducing health disparities and diseases among global communities. Provide examples of some global partnerships that are currently providing services in the international community.

For instance, what type of partnership you are exploring? Are you interested in public health organizations collaborating, such as the CDC and WHO? Or are you more interested in exploring companies or faith based organizations partnering with other countries, such as doctors without borders? How does the distinction change the way you view the partnership?

Solution Preview

Discuss some of the advantages of how global partnerships can assist in solving or reducing health disparities and diseases among global communities. Provide examples of some global partnerships that are currently providing services in the international community.

In developing countries people suffering from life-threatening conditions are often unable to access critical medicines for their treatment and survival. The high cost of medicines in relation to disposable income, low overall income and lack of health insurance coverage are determining factors of poor access, together with infrequent availability and poor quality. Besides access to medicines, there are significant barriers to accessing services, including lack of available infrastructure, lack of diagnostic capabilities, and poor transport options (Kanavos, Vandoros, Garcia-Gonzalez, 2009). To date increased health globalization promises faster growth, higher living standards and new opportunities for people in developing countries as well already developed countries.

Chronic Myeloid Leukemia (CML) is a rare, life threatening condition affecting between one and two people per 100,000 annually, and represents 15-20% of all cases of adult leukemia in Western societies. Treatment of CML involves the use of Imatinib (Glivec), this medication revolutionized the treatment and continued management of CML. The Glivec International Patient Assistance Program (GIPAP) is a program set up by a manufacturer (Novartis) to facilitate access to Imatinib for patients through their providers. GIPAP aims to fill the gaps of imperfect access to eligible patients in developing countries that cannot afford this costly treatment ...

Solution Summary

The expert discusses the advantages of how global partnerships can assist in solving or reducing health disparities and diseases among global communities.

$2.19